Clinical Trial Update: Antifungal Locks to Treat Fungal-related Central Line Infections [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating antifungal lock therapy for treating fungal-related central line infections completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Venous Catheter-associated Infection
• Fungal Infections

Drugs mentioned

• Antifungal lock therapy

Snippet

Sponsor: Bill McGhee | Conditions: Central Line Fungal Infections | Phase 4 | Status: COMPLETED | Results posted: 2017-10-10